Alcami Corporation, a U.S.-based contract development and manufacturing organization (CDMO), has completed its acquisition of Tjoapack, a global contract packaging organization with facilities in the United States and the Netherlands.
According to Alcami, this âstrategic integrationâ creates an end-to-end CDMO platform for pharma and biotech.
The combined organization now employs over 1,400 skilled personnel across the U.S. and the Netherlands. The acquisition also expands Alcamiâs operational footprint to more than 1 million square feet and supports the production of over 80 commercial products worldwide. Alcami CEO & Chairman Patrick Walsh will assume the CEO responsibility of the combined organizations.
The combined companies are advancing planned integration activities to expand end-to-end CDMO capabilities across the U.S. and Europe. According to Alcami, Tjoapack customers can expect uninterrupted service across all sites, while gaining access to Alcamiâs broad portfolio of capabilities, including drug product manufacturing, laboratory services, and pharma storage. Alcami customers will benefit from expanded packaging scale, increased supply chain redundancy, and enhanced market access support, including Qualified Person (QP) release services in Europe.
âThis acquisition represents a meaningful step forward in Alcamiâs long term growth strategy to provide integrated global solutions for our clientsâ, said Chairman and CEO Patrick Walsh. âWe welcome the Tjoapack team and look forward to unlocking the full potential of our combined capabilities.â
Other Pharma Industry Acquisitions
Check out Contract Pharmaâs Pharmaceutical Industry Mergers & Acquisitions Roundup.
